July 27, 1993 |
Four New Divisions: ICN Biomedicals Inc., a subsidiary of Costa Mesa-based drug conglomerate ICN Pharmaceuticals Inc., has just completed a restructuring. The company, which manufactures and sells chemicals and instruments for medical research and development, has divided itself into four divisions for greater efficiency, said ICN spokesman Paul Knopick.
July 18, 1991
ICN Biomedicals Inc. of Costa Mesa posted second-quarter earnings of $1.2 million, down 57% from earnings of $2.8 million in the year-earlier quarter. Revenue for the quarter ended May 31 declined 25% to $26.6 million from $35.3 million a year earlier. For the six-month period, earnings dropped 51% to $2.3 million from $4.7 million a year ago. Revenue declined 18% to $56.3 million from $68.3 million.